Latest news
Evotec enters R&D collaboration with Odyssey Therapeutics - TipRanksTipRanks · Thu, 06 Aug 2026 18:44:58 GMTNiagen Bioscience price target lowered to $10 from $12 at Roth Capital - TipRanksTipRanks · Wed, 05 Aug 2026 13:08:18 GMTNiagen Bioscience selects Evotec to advance development for NB4168 - TipRanksTipRanks · Mon, 03 Aug 2026 15:34:47 GMT